Medical Tourism and Experimental Gene Therapies with Liz Parrish

10/31/18 • 49 min

Liz Parish – CEO of BioViva

On this week’s episode of the How to Live to 200 podcast, we speak with Liz Parrish, CEO of BioViva. Join us as we go on a journey as we learn about Liz’s highly controversial medical tourism trip and the experimental gene therapies she’s using to cure aging. While many of our guests explore the boundaries of accepted treatments and standards, Liz’s experimentation takes things to a new level.

As CEO of BioViva, Liz works diligently to push accelerate innovation in gene therapy while democratizing critical information about the benefits of these new, bleeding-edge therapies. During this eye-opening conversation, we learn about the diagnoses that kickstarted her entrepreneurial journey to find a cure for kids. Along the way, we get a glimpse into the experimental world of gene therapies and the exciting new trends that Liz expects to see in the next wave of medicine. In this episode, we find out:

Why is Medical tourism big in Columbia?
What is the process of taking experimental gene therapies?
What results did Liz have after her gene therapies?
What is the delivery mechanism for gene therapies?
What is the future of telomerase injection?

If you’ve ever considered medical tourism, this episode is for you. We really enjoyed getting an in-depth look at the little-known world of medical tourism and the role it plays in pushing new treatments. Sit back, relax, and join us as we venture into the unknown.

About Liz

Show Links

Liz Parish – CEO of BioViva

Why is Medical tourism big in Columbia?
What is the process of taking experimental gene therapies?
What results did Liz have after her gene therapies?
What is the delivery mechanism for gene therapies?
What is the future of telomerase injection?

About Liz

Show Links

Previous Episode

When Science Fiction Becomes Reality – a Look into the Future with Ramez Naam

Ramez (Mez) Naam – Author and Futurist

Today’s guest is the famed author, entrepreneur, and futurist, Ramez (Mez) Naam. As an ex-Microsoft software engineering leader, Mez brings a unique perspective to the growing intersection between technology and wellness. After leaving Microsoft, Mez tried the more traditional technologist path and dove headfirst into building a startup. After spending a few years in the startup world, he decided to take some time away from building software to write his first book, More than Human. In many ways, that was just the beginning for Mez, as he soon found himself down the rabbit hole, exploring the science and technology at the thin line between science and fiction. Since then, he’s transitioned his passion for the bold ideas found in science fiction and the head-pounding adrenaline rush from the latest cutting-edge technologies, into an incredible career as an award-winning author and futurist. Today, Mez continues to write, speak, and play an influential role in the technology work, currently serving as a leader at the infamous Singularity University, where he focuses on energy exponential technologies.

In today’s episode, we run through some really interesting topics, touching on a mix of Mez’s vision for the future and the most recent hard science that fuels his writing. He also shares his process for finding, evaluating, and dissecting critical science and technology information. Below are a few of the highlights from our in-depth conversation:

Where Mez looks for inspiration for futuristic technologies
What technologies interest him most
How digital health in the developing world will change in the next 10 years
The dangers of self-hacking
Why Mez thinks of the genome as spaghetti code
Where and how human augmentation technologies will be applied in the near future
Why certain countries are poised for genetic enhancement breakthroughs
How rats are living to the human equivalent 200
When can we really expect designer babies to be the standard
Why Mez believes in a 3-minute workout

This podcast was incredibly energizing and eye-opening for our team, so we hope you enjoy it as much as we did.

About Ramez

Show Links

Next Episode

Finding a Cure for our Aging Brains

Leen Kawas – CEO, M3 Biotechnology

"There's work that needs to be done and we're going to do it." - Leen Kawas

Nothing better illustrates the grit, determination, and enthusiasm of today's guest, Leen Kawas. Leen is the CEO and president of M3 Biotechnology, a Seattle-based startup tackling diseases of the brain. As a leader in her field and an award-winning entrepreneur, she knows no bounds when it comes to tackling the daunting challenge of neurodegenerative diseases like Alzheimer's. As a Ph.D. student at Washington State University, Leen stumbled into an unlikely career as a startup CEO. But Leen's journey to entrepreneurship was completely unplanned.

As an immigrant from Jordan, Leen started her professional journey as a pharmacist. Not long into her career, Leen realized pharmacology didn't suit her ambitions, so she returned to academia, in pursuit of her Ph.D. at Washington State University. The opportunity to move from academia to the startup world came during her time at Washington State University. Like most great entrepreneurs, Leen saw the opportunity and felt compelled to change the status quo. Her passion, intelligence, and charisma quickly catapulted her to the role of CEO. And the rest is, as they say, history.

During our time with Leen, we explore the research behind M3 Biotechnology and find out:

What happens to our brains as we age?
What is a cognoscopy?
What data points can you use to address neurodegeneration?
What is the difference between small and large molecule treatments?

Leen's charm, wit, and ability to keep T.A. on his toes makes for an incredibly insightful and fun conversation. We hope you enjoy it as much as we did.

Note from Leen: M3 Biotechnology is introducing a new webpage and flyer to support recruitment for our NDX-1017 Phase 1 clinical trials. Please refer to our webpage at ndx-1017.com or call 1-800-839-2095 for more information. Thank you for your interest in our program and novel therapy for Alzheimer’s Disease.

About Leen

Show Links